SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial)
Name:
1-s2.0-S2451865421000697.pdf
Size:
3.588Mb
Format:
PDF
Description:
Final Published Version
Author
Sun, V.Crane, T.E.
Arnold, K.B.
Guthrie, K.
Freylersythe, S.
Braun-Inglis, C.
Jones, L.
Cohen, S.A.
Al-Kasspooles, M.
Krouse, R.S.
Thomson, C.A.
Affiliation
College of Nursing, University of ArizonaUniversity of Arizona Cancer Center
Mel and Enid Zuckerman College of Public Health, University of Arizona
Issue Date
2021
Metadata
Show full item recordPublisher
Elsevier Inc.Citation
Sun, V., Crane, T. E., Arnold, K. B., Guthrie, K., Freylersythe, S., Braun-Inglis, C., Jones, L., Cohen, S. A., Al-Kasspooles, M., Krouse, R. S., & Thomson, C. A. (2021). SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial). Contemporary Clinical Trials Communications, 22.Rights
Copyright © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Objective: To describe the study protocol of SWOG S1820, a trial of the Altering Intake, Managing Symptoms intervention for bowel dysfunction in survivors of Rectal Cancer (AIMS-RC). Design: SWOG S1820 is a multi-site, randomized trial of 94 post-treatment survivors of rectal cancer, comparing the intervention and attention control arms. Setting: Affiliated institutions of the National Cancer Institute (NCI)-supported National Community Oncology Research Program (NCORP) and the National Clinical Trial Network (NCTN). Participants: Survivors of rectal cancer who are between 6 and 24 months after treatment completion. Intervention: AIMS-RC is a 17-week, 10 session telephone coaching program to help survivors of rectal cancer track their symptoms and improve their diets for better health and bowel function. It includes telephone-based coaching, resource manual, and personalized text/email messaging for motivation in between the telephone sessions. Main outcome measures: Bowel function, low anterior resection syndrome score, quality of life (QOL), dietary quality, motivation, self-efficacy, positive/negative affect, feasibility, adherence, retention, acceptability. Analysis: Thirty-seven participants per arm (74 total) provide 80% power to detect this 0.5 standard deviation effect size, based on a two-sample t-test with a 1-sided alpha = 0.1. A total of 94 randomized participants will be accrued to account for 7% ineligibility and 15% attrition at 6 months. © 2021 The AuthorsNote
Open access journalISSN
2451-8654Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1016/j.conctc.2021.100768
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.